Tag: Iavi

April 7, 2022 Off

IAVI and Moderna Partner to Tackle Broad Global Health Priorities Using mRNA for Vaccines and Antibodies

Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the nonprofit scientific research organization IAVI have announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health threats.

March 27, 2019 Off

IAVI Announces First-in-Human Clinical Trial of Native-like HIV Envelope Vaccine Candidate

By BusinessWire

Phase I Trial to Evaluate Safety and Immunogenicity of Engineered Envelope Protein NEW YORK–(BUSINESS WIRE)–The International AIDS Vaccine Initiative (IAVI)…